Source: iQoncept / Shutterstock
Aerovate Therapeutics (NASDAQ:AVTE) just reported results for the first quarter of 2024.
- Aerovate Therapeutics reported earnings per share of -83 cents. This was below the analyst estimate for EPS of -68 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/avte-stock-earnings-aerovate-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC